Literature DB >> 10819807

Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma.

S Umhauer1, R J Ruch, J Fanning.   

Abstract

OBJECTIVES: Gap junctions, which are composed of subunits termed connexins, are plasma membrane channels that link the interior of adjacent cells and permit cells to directly exchange small molecules and ions. Loss or dysfunction of gap junctions appears to be important in allowing cancer cells to escape growth regulation. In a previous study we showed that human ovarian surface epithelial cells exhibited extensive gap junctions and expression of connexin 43. These were nearly absent in human ovarian adenocarcinoma cell lines. To ensure that this variation was not artificially produced by culturing techniques, this study evaluated gap junctions and connexin 43 expressions in normal ovaries and in ovarian adenocarcinomas. STUDY
DESIGN: Specimens of normal ovaries and ovarian adenocarcinomas were obtained at the time of surgery and flash-frozen in liquid nitrogen. Connexin 43 immunostaining was performed on all specimens.
RESULTS: Among the 11 normal ovaries an average of 59% of the surface epithelium stained positively for connexin 43. In contrast, among the 10 ovarian adenocarcinomas only 19% of each specimen stained positively for connexin 43 (P =.01).
CONCLUSION: Similar to our studies on human ovarian surface epithelial cells and ovarian adenocarcinoma cell lines, surgical specimens of normal ovary exhibited extensive connexin 43 expression, whereas connexin 43 expression was nearly absent in ovarian adenocarcinomas. It thus appears that the previously reported loss of gap junctions and connexin 43 was actually associated with a neoplastic process, rather than being artificially induced in the laboratory.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10819807     DOI: 10.1016/s0002-9378(00)70135-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.

Authors:  L Kanczuga-Koda; S Sulkowski; A Lenczewski; M Koda; A Wincewicz; M Baltaziak; M Sulkowska
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

2.  Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model.

Authors:  Paul C Roberts; Emilio P Mottillo; Andrea C Baxa; Henry H Q Heng; Nicole Doyon-Reale; Lucie Gregoire; Wayne D Lancaster; Raja Rabah; Eva M Schmelz
Journal:  Neoplasia       Date:  2005-10       Impact factor: 5.715

3.  Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.

Authors:  Yali Zhai; Rong Wu; Donald R Schwartz; Danielle Darrah; Heather Reed; Frank T Kolligs; Marvin T Nieman; Eric R Fearon; Kathleen R Cho
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

Review 4.  Revisiting the stimulus-secretion coupling in the adrenal medulla: role of gap junction-mediated intercellular communication.

Authors:  Claude Colomer; Michel G Desarménien; Nathalie C Guérineau
Journal:  Mol Neurobiol       Date:  2009-05-16       Impact factor: 5.590

5.  Inhibition of gap junctional Intercellular communication in WB-F344 rat liver epithelial cells by triphenyltin chloride through MAPK and PI3-kinase pathways.

Authors:  Chung-Hsun Lee; I-Hui Chen; Chia-Rong Lee; Chih-Hsien Chi; Ming-Che Tsai; Jin-Lian Tsai; Hsiu-Fen Lin
Journal:  J Occup Med Toxicol       Date:  2010-06-30       Impact factor: 2.646

6.  Connexin43 Expression Increases in the Epithelium and Stroma along the Colonic Neoplastic Progression Pathway: Implications for Its Oncogenic Role.

Authors:  Yusheng Han; Paul J Zhang; Terina Chen; Sabrina W Yum; Teresa Pasha; Emma E Furth
Journal:  Gastroenterol Res Pract       Date:  2011-06-30       Impact factor: 2.260

7.  Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition.

Authors:  Yan Yang; Shu-Kui Qin; Qiong Wu; Zi-Shu Wang; Rong-Sheng Zheng; Xu-Hui Tong; Hao Liu; Liang Tao; Xian-Di He
Journal:  Oncol Rep       Date:  2013-12-05       Impact factor: 3.906

8.  Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43.

Authors:  Shuyan Dai; Jingjing Liu; Xiaofei Sun; Ning Wang
Journal:  BMC Complement Altern Med       Date:  2014-11-05       Impact factor: 3.659

9.  Post-transcriptional regulation of connexin43 in H-Ras-transformed cells.

Authors:  Mustapha Kandouz; Jing Zhao; Andrew Bier; Sergio Di Marco; Irene Oviedo-Landaverde; Imed-Eddine Gallouzi; Gerald Batist
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

10.  Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.

Authors:  Cédric Poyet; Lorenz Buser; Filip Roudnicky; Michael Detmar; Thomas Hermanns; Doris Mannhard; Andrej Höhn; Jan Rüschoff; Qing Zhong; Tullio Sulser; Holger Moch; Peter J Wild
Journal:  J Clin Pathol       Date:  2015-08-06       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.